Office-Based Asthma Screening Intervention
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00156468|
Recruitment Status : Completed
First Posted : September 12, 2005
Last Update Posted : May 12, 2011
|Condition or disease||Intervention/treatment||Phase|
|Asthma||Behavioral: Provider Prompt||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||365 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Office-Based Asthma Screening Intervention|
|Study Start Date :||October 2003|
|Study Completion Date :||September 2005|
- "Preventive Medication Actions (PMA)" taken by the provider at the time of the child's visit. A "PMA" is defined as a new medication prescription or change in medication dose.
- Alternate actions taken by the provider such as: discussion of environmental controls, medication refills, etc.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00156468
|United States, New York|
|University of Rochester|
|Rochester, New York, United States, 14642|
|Principal Investigator:||Jill S Halterman, MD, MPH||University of Rochester|